1. Home
  2. KODK vs SPTX Comparison

KODK vs SPTX Comparison

Compare KODK & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastman Kodak Company

KODK

Eastman Kodak Company

BUY

Current Price

$10.12

Market Cap

982.9M

ML Signal

BUY

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$17.80

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KODK
SPTX
Founded
1880
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
982.9M
1.2B
IPO Year
1994
2026

Fundamental Metrics

Financial Performance
Metric
KODK
SPTX
Price
$10.12
$17.80
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $38.29
AVG Volume (30 Days)
★ 623.4K
193.3K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $4,114,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$5.78
$17.52
52 Week High
$14.87
$28.38

Technical Indicators

Market Signals
Indicator
KODK
SPTX
Relative Strength Index (RSI) 66.65 34.93
Support Level $8.87 N/A
Resistance Level $10.19 $22.75
Average True Range (ATR) 0.29 1.84
MACD 0.06 -0.41
Stochastic Oscillator 94.67 5.29

Price Performance

Historical Comparison
KODK
SPTX

About KODK Eastman Kodak Company

Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: